Familial papillary thyroid carcinoma is genetically distinct from familial adenomatous polyposis coli
Injectable semaglutide (Wegovy), oral semaglutide (Wegovy pill), liraglutide (Saxenda), phentermine/topiramate (Qsymia), and bupropion/naltrexone (Contrave) are all FDA-approved for obesity or chronic weight management
Studies link IGF-1 deficiency to impaired lipid profiles, insulin resistance, and cardiovascular risks
They compared weight loss outcomes in people taking chitosan supplements with those of people taking a placebo Results showed that chitosan supplementation slightly reduced body weight and body mass index (BMI) when paired with a calorie-restricted diet and physical activity These results support the findings of a similar, older review, which found that chitosan supplements may be more effective than a placebo as part of a short-term treatment plan for overweight and obesity Both reviews noted improvements in cholesterol levels and blood pressure Reduced cholesterol levels Chitosan may have a greater impact on cholesterol levels than on weight loss
GLP-1 receptor agonist medications often work well for people with this genetic type
Another hormone that affects metabolism and energy expenditure is FGF21